Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to evaluate the efficacy of an online platform that allows neurologists and therapists to exchange therapy recommendations, communicate assessments and plan physical therapy, occupational therapy as well as speech and swallowing therapy for their patients.

Detailed Description
-----------------
The aim of this study is to enroll 185 patients in the intervention group and 185 patients in the control group. Patients in the intervention group come from the same region (Münsterland), the control group will consist of patients outside this region. The patients in the intervention group undergo therapies planned and coordinated through the online platform for 12 months. The patients in the intervention group will be evaluated using the PDQ-39, UPDRS, H&Y as well as Schwab & England. The patients in the control group will be evaluated using the PDQ-39.

Official Title
-----------------
Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network- Evaluates the Efficacy of an Online Platform That Allows Neurologists and Therapists to Exchange Therapy Recommendations Regarding Their Patients With Parkinson's Disease (PwP), Communicate Assessments and Plan Physical Therapy, Occupational Therapy as Well as Speech and Swallowing Therapy

Conditions
-----------------
Parkinson Disease

Intervention / Treatment
-----------------
* Other: Coordination through the online platform JamesAKTIV


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria (Intervention Group): Idiopathic Parkinson's Disease with pharmacological treatment 30 years old or older place of residence: Münsterland, Tecklenburger Land, Kreis and Stadt Osnabrück sufficient knowledge of the German language, should be able to understand the consent form Exclusion Criteria: severe cognitive deficits Atypical Parkinsonian Disorders participation in other studies

Ages Eligible for Study
-----------------
Minimum Age: 30 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Intervention group<br>Patients in the intervention group come from the same region (Münsterland) and will undergo therapies coordinated through the online platform. | Other: Coordination through the online platform JamesAKTIV<br>* Coordination of the treatment through the online platform JamesAKTIV that allows neurologists and therapists to select specialised therapies for the predominant symptoms of the patients and communicate easily about problems during the treatment<br>|
| No Intervention: Control group<br>Patients in the control group will undergo their usual therapies as prescribed by their neurologists. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in Quality of Life measured by PDQ 39 | The Parkinson's Disease Questionnaire (PDQ-39, max. score of 100 indicates the worst quality of life) | Change from Baseline PDQ 39 at 12 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in Health-related resource use in the elderly population, assessed by FIMA | FIMA stands for Questionnaire concerning Health-related resource use in the elderly population and is a German questionnaire assessing the Health-related resource use in the elderly population | Change from Baseline FIMA at 12 months | 
| Change in disease severity measured by UPDRS | UPDRS - Unified Parkinson's Disease Rating Scale, max. score of 199 points indicates the worst outcome | Change from Baseline UPDRS at 12 months | 
| Change in disease severity measured by Hoehn & Yahr | Hoehn & Yahr is a simple scale that describes disease severity on a scale of 0-5, with 5 indicating severe disability | Change from Baseline UPDRS at 12 months | 
| Change in mobility, measured by Schwab- & England-Scale | Schwab- & England-Scale assesses the capabilities of people with impaired mobility. The scale uses percentages with 100% indicating full independence. | Change from Baseline Schwab-&England-Scale at 12 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Activities of Daily Living, Disease Management, Quality of Life, Rehabilitation, Patient-Centered Care, Delivery of Health Care, Integrated Care